Erypharm

Business Data, Corporate Office and Headquarter Address

About

Erypharm is Biotechnology in France that focus on developer business. They cover business area such as developer, a biotechnology process, red blood cell, any type, stem cell.

Business Type

Biotechnology

Country

France

Founded

-

Company Focus

Developer

Website

-

Corporate Office and Headquarter Office address:

27 rue Chaligny
75012 Paris
France

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

developera biotechnology processred blood cellany typestem cell

* We use standard office opening hours in near Erypharm's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

Erypharm Frequently Asked Questions

What or who is Erypharm?

Erypharm is Biotechnology business from France that founded in - ( years old in ), Erypharm business is focusing on Developer.

Where is Erypharm headquarter and corporate office address?

Erypharm headquarter office and corporate office address is located in 27 rue Chaligny 75012 Paris France.

Where is Erypharm country origins?

Erypharm was founded in France.

What is Developer business focus on?

In , Erypharm is currently focus on developer sector.

Developer Business Interest from Google Trend

Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.

Disclaimer: This website is not affiliated with Erypharm, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.